Page last updated: 2024-10-16

carnitine and Cancer of the Thymus

carnitine has been researched along with Cancer of the Thymus in 1 studies

Research Excerpts

ExcerptRelevanceReference
"The mechanism(s) of immune checkpoint inhibitor (ICI)-induced myasthenia gravis (MG), an immune-related adverse event (irAE) that is fatal and limits subsequent ICI use, remain unexplored."1.72Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis. ( Chen, L; Gao, W; Gong, Q; Guo, R; Jin, S; Li, J; Liu, X; Shao, YW; Shen, L; Sun, C; Wang, Q; Wang, W; Wang, Z; Wu, L; Xu, J; Yin, JC; Zhang, W, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gao, W3
Wu, L3
Jin, S3
Li, J3
Liu, X3
Xu, J3
Zhang, W3
Gong, Q3
Sun, C3
Wang, W3
Wang, Z3
Shao, YW3
Yin, JC3
Shen, L3
Chen, L3
Wang, Q3
Guo, R3

Other Studies

1 other study available for carnitine and Cancer of the Thymus

ArticleYear
Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis.
    Journal for immunotherapy of cancer, 2022, Volume: 10, Issue:11

    Topics: Carnitine; Humans; Immune Checkpoint Inhibitors; Myasthenia Gravis; Solute Carrier Family 22 Member

2022
Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis.
    Journal for immunotherapy of cancer, 2022, Volume: 10, Issue:11

    Topics: Carnitine; Humans; Immune Checkpoint Inhibitors; Myasthenia Gravis; Solute Carrier Family 22 Member

2022
Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis.
    Journal for immunotherapy of cancer, 2022, Volume: 10, Issue:11

    Topics: Carnitine; Humans; Immune Checkpoint Inhibitors; Myasthenia Gravis; Solute Carrier Family 22 Member

2022
Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis.
    Journal for immunotherapy of cancer, 2022, Volume: 10, Issue:11

    Topics: Carnitine; Humans; Immune Checkpoint Inhibitors; Myasthenia Gravis; Solute Carrier Family 22 Member

2022